nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP2D6—Niacin—atherosclerosis	0.0869	0.169	CbGbCtD
Rotigotine—CYP2D6—Simvastatin—atherosclerosis	0.0687	0.134	CbGbCtD
Rotigotine—CYP2D6—Pravastatin—atherosclerosis	0.0672	0.131	CbGbCtD
Rotigotine—CYP2D6—Lovastatin—atherosclerosis	0.0672	0.131	CbGbCtD
Rotigotine—CYP3A4—Rosuvastatin—atherosclerosis	0.047	0.0916	CbGbCtD
Rotigotine—CYP3A4—Ezetimibe—atherosclerosis	0.047	0.0916	CbGbCtD
Rotigotine—CYP3A4—Simvastatin—atherosclerosis	0.0437	0.0851	CbGbCtD
Rotigotine—CYP3A4—Pravastatin—atherosclerosis	0.0428	0.0833	CbGbCtD
Rotigotine—CYP3A4—Lovastatin—atherosclerosis	0.0428	0.0833	CbGbCtD
Rotigotine—Nightmare—Simvastatin—atherosclerosis	0.00263	0.00903	CcSEcCtD
Rotigotine—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00249	0.00856	CcSEcCtD
Rotigotine—Skin exfoliation—Niacin—atherosclerosis	0.00239	0.0082	CcSEcCtD
Rotigotine—Nightmare—Pravastatin—atherosclerosis	0.00238	0.00817	CcSEcCtD
Rotigotine—Fluid retention—Niacin—atherosclerosis	0.00238	0.00815	CcSEcCtD
Rotigotine—Sleep disorder—Simvastatin—atherosclerosis	0.00229	0.00784	CcSEcCtD
Rotigotine—Breast disorder—Rosuvastatin—atherosclerosis	0.00226	0.00774	CcSEcCtD
Rotigotine—Swelling—Simvastatin—atherosclerosis	0.00224	0.0077	CcSEcCtD
Rotigotine—Hot flush—Ezetimibe—atherosclerosis	0.00222	0.00761	CcSEcCtD
Rotigotine—Eczema—Simvastatin—atherosclerosis	0.0022	0.00756	CcSEcCtD
Rotigotine—Menopausal symptoms—Ezetimibe—atherosclerosis	0.0022	0.00755	CcSEcCtD
Rotigotine—Abnormal vision—Niacin—atherosclerosis	0.00218	0.00749	CcSEcCtD
Rotigotine—Sleep disorder—Pravastatin—atherosclerosis	0.00207	0.00709	CcSEcCtD
Rotigotine—Eczema—Niacin—atherosclerosis	0.00202	0.00694	CcSEcCtD
Rotigotine—Depression—Rosuvastatin—atherosclerosis	0.00192	0.00658	CcSEcCtD
Rotigotine—Hot flush—Pravastatin—atherosclerosis	0.00191	0.00656	CcSEcCtD
Rotigotine—Menopausal symptoms—Pravastatin—atherosclerosis	0.0019	0.00651	CcSEcCtD
Rotigotine—Breast disorder—Ezetimibe—atherosclerosis	0.00187	0.00643	CcSEcCtD
Rotigotine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00186	0.00637	CcSEcCtD
Rotigotine—Sinusitis—Rosuvastatin—atherosclerosis	0.0018	0.00619	CcSEcCtD
Rotigotine—Disturbance in sexual arousal—Niacin—atherosclerosis	0.0018	0.00619	CcSEcCtD
Rotigotine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00168	0.00578	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00167	0.00572	CcSEcCtD
Rotigotine—Orthostatic hypotension—Niacin—atherosclerosis	0.00166	0.00569	CcSEcCtD
Rotigotine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00165	0.00567	CcSEcCtD
Rotigotine—Nasopharyngitis—Pravastatin—atherosclerosis	0.0016	0.00549	CcSEcCtD
Rotigotine—Infestation NOS—Ezetimibe—atherosclerosis	0.0016	0.00549	CcSEcCtD
Rotigotine—Infestation—Ezetimibe—atherosclerosis	0.0016	0.00549	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00159	0.00545	CcSEcCtD
Rotigotine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00157	0.0054	CcSEcCtD
Rotigotine—Sinusitis—Lovastatin—atherosclerosis	0.00153	0.00525	CcSEcCtD
Rotigotine—Depression—Simvastatin—atherosclerosis	0.00152	0.00522	CcSEcCtD
Rotigotine—Mental disorder—Rosuvastatin—atherosclerosis	0.00151	0.00519	CcSEcCtD
Rotigotine—Sweating increased—Pravastatin—atherosclerosis	0.00151	0.00517	CcSEcCtD
Rotigotine—Sinusitis—Ezetimibe—atherosclerosis	0.0015	0.00515	CcSEcCtD
Rotigotine—Erectile dysfunction—Niacin—atherosclerosis	0.00145	0.00496	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00144	0.00493	CcSEcCtD
Rotigotine—Sinusitis—Simvastatin—atherosclerosis	0.00143	0.00491	CcSEcCtD
Rotigotine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00142	0.00489	CcSEcCtD
Rotigotine—Oedema peripheral—Ezetimibe—atherosclerosis	0.00141	0.00485	CcSEcCtD
Rotigotine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00141	0.00484	CcSEcCtD
Rotigotine—Weight increased—Pravastatin—atherosclerosis	0.00141	0.00483	CcSEcCtD
Rotigotine—Weight decreased—Pravastatin—atherosclerosis	0.0014	0.0048	CcSEcCtD
Rotigotine—Depression—Pravastatin—atherosclerosis	0.00137	0.00472	CcSEcCtD
Rotigotine—Angioedema—Rosuvastatin—atherosclerosis	0.00137	0.00471	CcSEcCtD
Rotigotine—Cough—Rosuvastatin—atherosclerosis	0.00131	0.0045	CcSEcCtD
Rotigotine—Angiopathy—Ezetimibe—atherosclerosis	0.0013	0.00447	CcSEcCtD
Rotigotine—Immune system disorder—Ezetimibe—atherosclerosis	0.0013	0.00445	CcSEcCtD
Rotigotine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00129	0.00444	CcSEcCtD
Rotigotine—Sinusitis—Pravastatin—atherosclerosis	0.00129	0.00444	CcSEcCtD
Rotigotine—Arthralgia—Rosuvastatin—atherosclerosis	0.00128	0.00439	CcSEcCtD
Rotigotine—Mental disorder—Ezetimibe—atherosclerosis	0.00126	0.00432	CcSEcCtD
Rotigotine—Erythema—Ezetimibe—atherosclerosis	0.00125	0.00429	CcSEcCtD
Rotigotine—Malnutrition—Ezetimibe—atherosclerosis	0.00125	0.00429	CcSEcCtD
Rotigotine—Oedema peripheral—Niacin—atherosclerosis	0.00124	0.00425	CcSEcCtD
Rotigotine—Confusional state—Rosuvastatin—atherosclerosis	0.00124	0.00425	CcSEcCtD
Rotigotine—Muscle spasms—Lovastatin—atherosclerosis	0.00122	0.0042	CcSEcCtD
Rotigotine—Infection—Rosuvastatin—atherosclerosis	0.00122	0.00418	CcSEcCtD
Rotigotine—Visual impairment—Niacin—atherosclerosis	0.00121	0.00416	CcSEcCtD
Rotigotine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.0012	0.00413	CcSEcCtD
Rotigotine—Muscle spasms—Ezetimibe—atherosclerosis	0.0012	0.00412	CcSEcCtD
Rotigotine—Mental disorder—Simvastatin—atherosclerosis	0.0012	0.00412	CcSEcCtD
Rotigotine—Tremor—Lovastatin—atherosclerosis	0.00119	0.0041	CcSEcCtD
Rotigotine—Visual impairment—Pravastatin—atherosclerosis	0.00119	0.00409	CcSEcCtD
Rotigotine—Erythema—Simvastatin—atherosclerosis	0.00119	0.00409	CcSEcCtD
Rotigotine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00118	0.00406	CcSEcCtD
Rotigotine—Tinnitus—Niacin—atherosclerosis	0.00117	0.00402	CcSEcCtD
Rotigotine—Angioedema—Lovastatin—atherosclerosis	0.00116	0.00399	CcSEcCtD
Rotigotine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00116	0.00398	CcSEcCtD
Rotigotine—Tinnitus—Pravastatin—atherosclerosis	0.00115	0.00396	CcSEcCtD
Rotigotine—Malaise—Lovastatin—atherosclerosis	0.00115	0.00394	CcSEcCtD
Rotigotine—Muscle spasms—Simvastatin—atherosclerosis	0.00115	0.00393	CcSEcCtD
Rotigotine—Vertigo—Lovastatin—atherosclerosis	0.00114	0.00393	CcSEcCtD
Rotigotine—Angioedema—Ezetimibe—atherosclerosis	0.00114	0.00392	CcSEcCtD
Rotigotine—Angiopathy—Niacin—atherosclerosis	0.00114	0.00391	CcSEcCtD
Rotigotine—Malaise—Ezetimibe—atherosclerosis	0.00113	0.00387	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00112	0.00384	CcSEcCtD
Rotigotine—Tremor—Simvastatin—atherosclerosis	0.00112	0.00383	CcSEcCtD
Rotigotine—Insomnia—Rosuvastatin—atherosclerosis	0.00111	0.00381	CcSEcCtD
Rotigotine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00111	0.00379	CcSEcCtD
Rotigotine—Paraesthesia—Rosuvastatin—atherosclerosis	0.0011	0.00378	CcSEcCtD
Rotigotine—Malnutrition—Niacin—atherosclerosis	0.00109	0.00375	CcSEcCtD
Rotigotine—Erythema—Niacin—atherosclerosis	0.00109	0.00375	CcSEcCtD
Rotigotine—Cough—Ezetimibe—atherosclerosis	0.00109	0.00374	CcSEcCtD
Rotigotine—Angioedema—Simvastatin—atherosclerosis	0.00109	0.00374	CcSEcCtD
Rotigotine—Arthralgia—Lovastatin—atherosclerosis	0.00108	0.00372	CcSEcCtD
Rotigotine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00108	0.00371	CcSEcCtD
Rotigotine—Hypertension—Ezetimibe—atherosclerosis	0.00108	0.0037	CcSEcCtD
Rotigotine—Malaise—Simvastatin—atherosclerosis	0.00107	0.00369	CcSEcCtD
Rotigotine—Discomfort—Lovastatin—atherosclerosis	0.00107	0.00368	CcSEcCtD
Rotigotine—Vertigo—Simvastatin—atherosclerosis	0.00107	0.00367	CcSEcCtD
Rotigotine—Arthralgia—Ezetimibe—atherosclerosis	0.00106	0.00365	CcSEcCtD
Rotigotine—Dry mouth—Lovastatin—atherosclerosis	0.00106	0.00364	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00106	0.00363	CcSEcCtD
Rotigotine—Muscle spasms—Niacin—atherosclerosis	0.00105	0.00361	CcSEcCtD
Rotigotine—Discomfort—Ezetimibe—atherosclerosis	0.00105	0.00361	CcSEcCtD
Rotigotine—Pain—Rosuvastatin—atherosclerosis	0.00105	0.0036	CcSEcCtD
Rotigotine—Constipation—Rosuvastatin—atherosclerosis	0.00105	0.0036	CcSEcCtD
Rotigotine—Confusional state—Lovastatin—atherosclerosis	0.00105	0.0036	CcSEcCtD
Rotigotine—Dry mouth—Ezetimibe—atherosclerosis	0.00104	0.00357	CcSEcCtD
Rotigotine—Muscle spasms—Pravastatin—atherosclerosis	0.00104	0.00355	CcSEcCtD
Rotigotine—Infection—Lovastatin—atherosclerosis	0.00103	0.00354	CcSEcCtD
Rotigotine—Confusional state—Ezetimibe—atherosclerosis	0.00103	0.00353	CcSEcCtD
Rotigotine—Arthralgia—Simvastatin—atherosclerosis	0.00101	0.00348	CcSEcCtD
Rotigotine—Infection—Ezetimibe—atherosclerosis	0.00101	0.00348	CcSEcCtD
Rotigotine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00101	0.00347	CcSEcCtD
Rotigotine—Tremor—Pravastatin—atherosclerosis	0.00101	0.00346	CcSEcCtD
Rotigotine—Discomfort—Simvastatin—atherosclerosis	0.001	0.00344	CcSEcCtD
Rotigotine—Nervous system disorder—Ezetimibe—atherosclerosis	0.001	0.00343	CcSEcCtD
Rotigotine—Angioedema—Niacin—atherosclerosis	0.001	0.00343	CcSEcCtD
Rotigotine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000999	0.00343	CcSEcCtD
Rotigotine—Anorexia—Lovastatin—atherosclerosis	0.000991	0.0034	CcSEcCtD
Rotigotine—Skin disorder—Ezetimibe—atherosclerosis	0.00099	0.0034	CcSEcCtD
Rotigotine—Angioedema—Pravastatin—atherosclerosis	0.000984	0.00338	CcSEcCtD
Rotigotine—Vertigo—Niacin—atherosclerosis	0.000983	0.00337	CcSEcCtD
Rotigotine—Syncope—Niacin—atherosclerosis	0.000981	0.00337	CcSEcCtD
Rotigotine—Confusional state—Simvastatin—atherosclerosis	0.00098	0.00336	CcSEcCtD
Rotigotine—Urticaria—Rosuvastatin—atherosclerosis	0.000974	0.00334	CcSEcCtD
Rotigotine—Malaise—Pravastatin—atherosclerosis	0.000971	0.00333	CcSEcCtD
Rotigotine—Vertigo—Pravastatin—atherosclerosis	0.000968	0.00332	CcSEcCtD
Rotigotine—Infection—Simvastatin—atherosclerosis	0.000966	0.00332	CcSEcCtD
Rotigotine—Loss of consciousness—Niacin—atherosclerosis	0.000962	0.0033	CcSEcCtD
Rotigotine—Cough—Niacin—atherosclerosis	0.000955	0.00328	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000947	0.00325	CcSEcCtD
Rotigotine—Insomnia—Lovastatin—atherosclerosis	0.00094	0.00323	CcSEcCtD
Rotigotine—Cough—Pravastatin—atherosclerosis	0.00094	0.00323	CcSEcCtD
Rotigotine—Paraesthesia—Lovastatin—atherosclerosis	0.000933	0.0032	CcSEcCtD
Rotigotine—Arthralgia—Niacin—atherosclerosis	0.000931	0.0032	CcSEcCtD
Rotigotine—Hypertension—Pravastatin—atherosclerosis	0.00093	0.00319	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000929	0.00319	CcSEcCtD
Rotigotine—Anorexia—Simvastatin—atherosclerosis	0.000927	0.00318	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000925	0.00317	CcSEcCtD
Rotigotine—Insomnia—Ezetimibe—atherosclerosis	0.000922	0.00317	CcSEcCtD
Rotigotine—Arthralgia—Pravastatin—atherosclerosis	0.000917	0.00315	CcSEcCtD
Rotigotine—Paraesthesia—Ezetimibe—atherosclerosis	0.000916	0.00314	CcSEcCtD
Rotigotine—Dyspepsia—Lovastatin—atherosclerosis	0.000915	0.00314	CcSEcCtD
Rotigotine—Dry mouth—Niacin—atherosclerosis	0.000911	0.00313	CcSEcCtD
Rotigotine—Discomfort—Pravastatin—atherosclerosis	0.000906	0.00311	CcSEcCtD
Rotigotine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000904	0.0031	CcSEcCtD
Rotigotine—Decreased appetite—Lovastatin—atherosclerosis	0.000904	0.0031	CcSEcCtD
Rotigotine—Dyspepsia—Ezetimibe—atherosclerosis	0.000898	0.00308	CcSEcCtD
Rotigotine—Fatigue—Lovastatin—atherosclerosis	0.000896	0.00308	CcSEcCtD
Rotigotine—Pain—Lovastatin—atherosclerosis	0.000889	0.00305	CcSEcCtD
Rotigotine—Constipation—Lovastatin—atherosclerosis	0.000889	0.00305	CcSEcCtD
Rotigotine—Confusional state—Pravastatin—atherosclerosis	0.000886	0.00304	CcSEcCtD
Rotigotine—Decreased appetite—Ezetimibe—atherosclerosis	0.000886	0.00304	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000886	0.00304	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00088	0.00302	CcSEcCtD
Rotigotine—Asthenia—Rosuvastatin—atherosclerosis	0.00088	0.00302	CcSEcCtD
Rotigotine—Insomnia—Simvastatin—atherosclerosis	0.000879	0.00302	CcSEcCtD
Rotigotine—Fatigue—Ezetimibe—atherosclerosis	0.000879	0.00302	CcSEcCtD
Rotigotine—Shock—Niacin—atherosclerosis	0.000878	0.00301	CcSEcCtD
Rotigotine—Infection—Pravastatin—atherosclerosis	0.000873	0.003	CcSEcCtD
Rotigotine—Paraesthesia—Simvastatin—atherosclerosis	0.000873	0.003	CcSEcCtD
Rotigotine—Pain—Ezetimibe—atherosclerosis	0.000872	0.00299	CcSEcCtD
Rotigotine—Constipation—Ezetimibe—atherosclerosis	0.000872	0.00299	CcSEcCtD
Rotigotine—Pruritus—Rosuvastatin—atherosclerosis	0.000868	0.00298	CcSEcCtD
Rotigotine—Skin disorder—Niacin—atherosclerosis	0.000867	0.00298	CcSEcCtD
Rotigotine—Hyperhidrosis—Niacin—atherosclerosis	0.000863	0.00296	CcSEcCtD
Rotigotine—Feeling abnormal—Lovastatin—atherosclerosis	0.000857	0.00294	CcSEcCtD
Rotigotine—Dyspepsia—Simvastatin—atherosclerosis	0.000856	0.00294	CcSEcCtD
Rotigotine—Anorexia—Niacin—atherosclerosis	0.000851	0.00292	CcSEcCtD
Rotigotine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00085	0.00292	CcSEcCtD
Rotigotine—Decreased appetite—Simvastatin—atherosclerosis	0.000845	0.0029	CcSEcCtD
Rotigotine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00084	0.00288	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000839	0.00288	CcSEcCtD
Rotigotine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000839	0.00288	CcSEcCtD
Rotigotine—Fatigue—Simvastatin—atherosclerosis	0.000838	0.00288	CcSEcCtD
Rotigotine—Anorexia—Pravastatin—atherosclerosis	0.000838	0.00288	CcSEcCtD
Rotigotine—Hypotension—Niacin—atherosclerosis	0.000834	0.00286	CcSEcCtD
Rotigotine—Pain—Simvastatin—atherosclerosis	0.000832	0.00285	CcSEcCtD
Rotigotine—Constipation—Simvastatin—atherosclerosis	0.000832	0.00285	CcSEcCtD
Rotigotine—Urticaria—Lovastatin—atherosclerosis	0.000826	0.00283	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000813	0.00279	CcSEcCtD
Rotigotine—Dizziness—Rosuvastatin—atherosclerosis	0.000811	0.00278	CcSEcCtD
Rotigotine—Urticaria—Ezetimibe—atherosclerosis	0.00081	0.00278	CcSEcCtD
Rotigotine—Insomnia—Niacin—atherosclerosis	0.000808	0.00277	CcSEcCtD
Rotigotine—Paraesthesia—Niacin—atherosclerosis	0.000802	0.00275	CcSEcCtD
Rotigotine—Feeling abnormal—Simvastatin—atherosclerosis	0.000801	0.00275	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000801	0.00275	CcSEcCtD
Rotigotine—Insomnia—Pravastatin—atherosclerosis	0.000795	0.00273	CcSEcCtD
Rotigotine—Somnolence—Niacin—atherosclerosis	0.000794	0.00272	CcSEcCtD
Rotigotine—Paraesthesia—Pravastatin—atherosclerosis	0.000789	0.00271	CcSEcCtD
Rotigotine—Dyspepsia—Niacin—atherosclerosis	0.000786	0.0027	CcSEcCtD
Rotigotine—Decreased appetite—Niacin—atherosclerosis	0.000776	0.00266	CcSEcCtD
Rotigotine—Dyspepsia—Pravastatin—atherosclerosis	0.000774	0.00266	CcSEcCtD
Rotigotine—Rash—Rosuvastatin—atherosclerosis	0.000773	0.00265	CcSEcCtD
Rotigotine—Dermatitis—Rosuvastatin—atherosclerosis	0.000773	0.00265	CcSEcCtD
Rotigotine—Urticaria—Simvastatin—atherosclerosis	0.000772	0.00265	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000771	0.00265	CcSEcCtD
Rotigotine—Headache—Rosuvastatin—atherosclerosis	0.000768	0.00264	CcSEcCtD
Rotigotine—Hypersensitivity—Lovastatin—atherosclerosis	0.000766	0.00263	CcSEcCtD
Rotigotine—Decreased appetite—Pravastatin—atherosclerosis	0.000764	0.00262	CcSEcCtD
Rotigotine—Pain—Niacin—atherosclerosis	0.000764	0.00262	CcSEcCtD
Rotigotine—Fatigue—Pravastatin—atherosclerosis	0.000758	0.0026	CcSEcCtD
Rotigotine—Constipation—Pravastatin—atherosclerosis	0.000752	0.00258	CcSEcCtD
Rotigotine—Pain—Pravastatin—atherosclerosis	0.000752	0.00258	CcSEcCtD
Rotigotine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000751	0.00258	CcSEcCtD
Rotigotine—Asthenia—Lovastatin—atherosclerosis	0.000746	0.00256	CcSEcCtD
Rotigotine—Pruritus—Lovastatin—atherosclerosis	0.000735	0.00252	CcSEcCtD
Rotigotine—Asthenia—Ezetimibe—atherosclerosis	0.000732	0.00251	CcSEcCtD
Rotigotine—Nausea—Rosuvastatin—atherosclerosis	0.000729	0.0025	CcSEcCtD
Rotigotine—Feeling abnormal—Pravastatin—atherosclerosis	0.000724	0.00249	CcSEcCtD
Rotigotine—Pruritus—Ezetimibe—atherosclerosis	0.000721	0.00248	CcSEcCtD
Rotigotine—Hypersensitivity—Simvastatin—atherosclerosis	0.000716	0.00246	CcSEcCtD
Rotigotine—Diarrhoea—Lovastatin—atherosclerosis	0.000711	0.00244	CcSEcCtD
Rotigotine—Urticaria—Niacin—atherosclerosis	0.000709	0.00243	CcSEcCtD
Rotigotine—Urticaria—Pravastatin—atherosclerosis	0.000698	0.0024	CcSEcCtD
Rotigotine—Asthenia—Simvastatin—atherosclerosis	0.000698	0.00239	CcSEcCtD
Rotigotine—Diarrhoea—Ezetimibe—atherosclerosis	0.000698	0.00239	CcSEcCtD
Rotigotine—Pruritus—Simvastatin—atherosclerosis	0.000688	0.00236	CcSEcCtD
Rotigotine—Dizziness—Lovastatin—atherosclerosis	0.000687	0.00236	CcSEcCtD
Rotigotine—Dizziness—Ezetimibe—atherosclerosis	0.000674	0.00231	CcSEcCtD
Rotigotine—Diarrhoea—Simvastatin—atherosclerosis	0.000665	0.00228	CcSEcCtD
Rotigotine—Vomiting—Lovastatin—atherosclerosis	0.000661	0.00227	CcSEcCtD
Rotigotine—Hypersensitivity—Niacin—atherosclerosis	0.000658	0.00226	CcSEcCtD
Rotigotine—Rash—Lovastatin—atherosclerosis	0.000655	0.00225	CcSEcCtD
Rotigotine—Dermatitis—Lovastatin—atherosclerosis	0.000655	0.00225	CcSEcCtD
Rotigotine—Headache—Lovastatin—atherosclerosis	0.000651	0.00224	CcSEcCtD
Rotigotine—Vomiting—Ezetimibe—atherosclerosis	0.000648	0.00223	CcSEcCtD
Rotigotine—Hypersensitivity—Pravastatin—atherosclerosis	0.000648	0.00222	CcSEcCtD
Rotigotine—Dizziness—Simvastatin—atherosclerosis	0.000643	0.00221	CcSEcCtD
Rotigotine—Rash—Ezetimibe—atherosclerosis	0.000643	0.00221	CcSEcCtD
Rotigotine—Dermatitis—Ezetimibe—atherosclerosis	0.000642	0.0022	CcSEcCtD
Rotigotine—Asthenia—Niacin—atherosclerosis	0.000641	0.0022	CcSEcCtD
Rotigotine—Headache—Ezetimibe—atherosclerosis	0.000639	0.00219	CcSEcCtD
Rotigotine—Pruritus—Niacin—atherosclerosis	0.000632	0.00217	CcSEcCtD
Rotigotine—Asthenia—Pravastatin—atherosclerosis	0.000631	0.00216	CcSEcCtD
Rotigotine—Pruritus—Pravastatin—atherosclerosis	0.000622	0.00213	CcSEcCtD
Rotigotine—Vomiting—Simvastatin—atherosclerosis	0.000618	0.00212	CcSEcCtD
Rotigotine—Nausea—Lovastatin—atherosclerosis	0.000617	0.00212	CcSEcCtD
Rotigotine—Rash—Simvastatin—atherosclerosis	0.000613	0.0021	CcSEcCtD
Rotigotine—Dermatitis—Simvastatin—atherosclerosis	0.000613	0.0021	CcSEcCtD
Rotigotine—Diarrhoea—Niacin—atherosclerosis	0.000611	0.0021	CcSEcCtD
Rotigotine—Headache—Simvastatin—atherosclerosis	0.000609	0.00209	CcSEcCtD
Rotigotine—Nausea—Ezetimibe—atherosclerosis	0.000606	0.00208	CcSEcCtD
Rotigotine—Diarrhoea—Pravastatin—atherosclerosis	0.000601	0.00206	CcSEcCtD
Rotigotine—Dizziness—Niacin—atherosclerosis	0.00059	0.00203	CcSEcCtD
Rotigotine—Dizziness—Pravastatin—atherosclerosis	0.000581	0.002	CcSEcCtD
Rotigotine—Nausea—Simvastatin—atherosclerosis	0.000578	0.00198	CcSEcCtD
Rotigotine—Vomiting—Niacin—atherosclerosis	0.000568	0.00195	CcSEcCtD
Rotigotine—Rash—Niacin—atherosclerosis	0.000563	0.00193	CcSEcCtD
Rotigotine—Dermatitis—Niacin—atherosclerosis	0.000562	0.00193	CcSEcCtD
Rotigotine—Headache—Niacin—atherosclerosis	0.000559	0.00192	CcSEcCtD
Rotigotine—Vomiting—Pravastatin—atherosclerosis	0.000559	0.00192	CcSEcCtD
Rotigotine—Rash—Pravastatin—atherosclerosis	0.000554	0.0019	CcSEcCtD
Rotigotine—Dermatitis—Pravastatin—atherosclerosis	0.000554	0.0019	CcSEcCtD
Rotigotine—Headache—Pravastatin—atherosclerosis	0.000551	0.00189	CcSEcCtD
Rotigotine—Nausea—Niacin—atherosclerosis	0.00053	0.00182	CcSEcCtD
Rotigotine—Nausea—Pravastatin—atherosclerosis	0.000522	0.00179	CcSEcCtD
Rotigotine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.13e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	2.12e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCL2—atherosclerosis	2.12e-05	0.000108	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	2.11e-05	0.000108	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—F2—atherosclerosis	2.11e-05	0.000108	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EDN1—atherosclerosis	2.11e-05	0.000108	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL5—atherosclerosis	2.09e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IGF1—atherosclerosis	2.08e-05	0.000107	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AGT—atherosclerosis	2.06e-05	0.000106	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—AKT1—atherosclerosis	2.05e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MMP9—atherosclerosis	2.05e-05	0.000105	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.05e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CG—atherosclerosis	2.05e-05	0.000105	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—LPL—atherosclerosis	2.04e-05	0.000105	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	2.04e-05	0.000104	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.04e-05	0.000104	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NFKB1—atherosclerosis	2.03e-05	0.000104	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—APOE—atherosclerosis	2.02e-05	0.000103	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—LEP—atherosclerosis	2.02e-05	0.000103	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CG—atherosclerosis	2.02e-05	0.000103	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.02e-05	0.000103	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOA2—atherosclerosis	2.02e-05	0.000103	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.02e-05	0.000103	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.02e-05	0.000103	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	2e-05	0.000103	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	2e-05	0.000102	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MAPK8—atherosclerosis	2e-05	0.000102	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.99e-05	0.000102	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AGT—atherosclerosis	1.99e-05	0.000102	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.99e-05	0.000102	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—AKT1—atherosclerosis	1.99e-05	0.000102	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PRKCG—atherosclerosis	1.99e-05	0.000102	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.98e-05	0.000101	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.98e-05	0.000101	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SERPINE1—atherosclerosis	1.98e-05	0.000101	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.97e-05	0.000101	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—MAPK3—atherosclerosis	1.96e-05	0.0001	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.95e-05	0.0001	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—LEP—atherosclerosis	1.95e-05	9.99e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—APOE—atherosclerosis	1.95e-05	9.99e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—INS—atherosclerosis	1.94e-05	9.93e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SPP1—atherosclerosis	1.94e-05	9.91e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—MAPK3—atherosclerosis	1.93e-05	9.91e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CAV1—atherosclerosis	1.93e-05	9.9e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	1.93e-05	9.88e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—APOA1—atherosclerosis	1.93e-05	9.88e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	1.93e-05	9.87e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—LPA—atherosclerosis	1.92e-05	9.85e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—INS—atherosclerosis	1.91e-05	9.79e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CETP—atherosclerosis	1.91e-05	9.78e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCL2—atherosclerosis	1.91e-05	9.77e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—F2—atherosclerosis	1.91e-05	9.76e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOS3—atherosclerosis	1.89e-05	9.67e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCL2—atherosclerosis	1.88e-05	9.64e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IGF1—atherosclerosis	1.87e-05	9.6e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ESR1—atherosclerosis	1.86e-05	9.54e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—BGN—atherosclerosis	1.86e-05	9.54e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IGF1—atherosclerosis	1.85e-05	9.47e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.84e-05	9.44e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VEGFA—atherosclerosis	1.84e-05	9.44e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—F2—atherosclerosis	1.84e-05	9.42e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.83e-05	9.36e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—STAT3—atherosclerosis	1.82e-05	9.34e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	1.82e-05	9.34e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.82e-05	9.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PDGFB—atherosclerosis	1.79e-05	9.17e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.78e-05	9.12e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.78e-05	9.12e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.77e-05	9.09e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	1.76e-05	9.02e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SERPINE1—atherosclerosis	1.76e-05	9e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AGT—atherosclerosis	1.75e-05	8.95e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	1.75e-05	8.94e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MAPK3—atherosclerosis	1.74e-05	8.93e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.73e-05	8.84e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—INS—atherosclerosis	1.73e-05	8.84e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.71e-05	8.78e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—LEP—atherosclerosis	1.71e-05	8.77e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOE—atherosclerosis	1.71e-05	8.77e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOS3—atherosclerosis	1.7e-05	8.7e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	1.7e-05	8.7e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CAV1—atherosclerosis	1.7e-05	8.69e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOA1—atherosclerosis	1.69e-05	8.67e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TGFB1—atherosclerosis	1.69e-05	8.66e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	1.69e-05	8.63e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOS3—atherosclerosis	1.68e-05	8.59e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CXCL8—atherosclerosis	1.67e-05	8.58e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	1.67e-05	8.55e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—INS—atherosclerosis	1.67e-05	8.53e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCL2—atherosclerosis	1.64e-05	8.4e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ESR1—atherosclerosis	1.64e-05	8.37e-05	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—atherosclerosis	1.62e-05	8.28e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—F2—atherosclerosis	1.62e-05	8.27e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IGF1—atherosclerosis	1.61e-05	8.26e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL6—atherosclerosis	1.59e-05	8.16e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	1.59e-05	8.12e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.56e-05	7.98e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.56e-05	7.98e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	1.55e-05	7.92e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.54e-05	7.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.54e-05	7.87e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	1.53e-05	7.84e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.53e-05	7.82e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.52e-05	7.77e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—atherosclerosis	1.51e-05	7.76e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	1.51e-05	7.75e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.51e-05	7.73e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL8—atherosclerosis	1.51e-05	7.72e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NFKB1—atherosclerosis	1.5e-05	7.67e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOB—atherosclerosis	1.49e-05	7.65e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—atherosclerosis	1.49e-05	7.62e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	1.48e-05	7.58e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CETP—atherosclerosis	1.47e-05	7.55e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK8—atherosclerosis	1.47e-05	7.54e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—atherosclerosis	1.47e-05	7.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—INS—atherosclerosis	1.46e-05	7.49e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOS3—atherosclerosis	1.46e-05	7.48e-05	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	1.46e-05	7.46e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.45e-05	7.44e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL2—atherosclerosis	1.44e-05	7.37e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	1.44e-05	7.36e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—atherosclerosis	1.43e-05	7.34e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—LPL—atherosclerosis	1.43e-05	7.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IGF1—atherosclerosis	1.42e-05	7.25e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—atherosclerosis	1.41e-05	7.24e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.41e-05	7.23e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GPX1—atherosclerosis	1.39e-05	7.12e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—atherosclerosis	1.36e-05	6.98e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—atherosclerosis	1.36e-05	6.97e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CD36—atherosclerosis	1.35e-05	6.94e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NFKB1—atherosclerosis	1.35e-05	6.91e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—atherosclerosis	1.35e-05	6.9e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—atherosclerosis	1.35e-05	6.89e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	1.34e-05	6.88e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	1.34e-05	6.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.33e-05	6.82e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NFKB1—atherosclerosis	1.33e-05	6.82e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	1.33e-05	6.79e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	1.32e-05	6.77e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.32e-05	6.76e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK8—atherosclerosis	1.31e-05	6.7e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—atherosclerosis	1.3e-05	6.68e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	1.3e-05	6.64e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	1.3e-05	6.64e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK3—atherosclerosis	1.29e-05	6.59e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.28e-05	6.57e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOS3—atherosclerosis	1.28e-05	6.57e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	1.28e-05	6.54e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—atherosclerosis	1.27e-05	6.53e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOB—atherosclerosis	1.26e-05	6.48e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARA—atherosclerosis	1.26e-05	6.45e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	1.25e-05	6.41e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—atherosclerosis	1.25e-05	6.39e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	1.23e-05	6.31e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.23e-05	6.3e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	1.22e-05	6.27e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AGT—atherosclerosis	1.22e-05	6.25e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	1.21e-05	6.22e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—atherosclerosis	1.21e-05	6.21e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—atherosclerosis	1.21e-05	6.19e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—LPL—atherosclerosis	1.21e-05	6.18e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	1.2e-05	6.15e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—atherosclerosis	1.2e-05	6.13e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOE—atherosclerosis	1.19e-05	6.12e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.19e-05	6.08e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CAV1—atherosclerosis	1.18e-05	6.06e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	1.18e-05	6.05e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOA1—atherosclerosis	1.18e-05	6.05e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GPX1—atherosclerosis	1.18e-05	6.03e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	1.18e-05	6.03e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—atherosclerosis	1.18e-05	6.02e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	1.17e-05	6.01e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	1.16e-05	5.94e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	1.16e-05	5.93e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CD36—atherosclerosis	1.15e-05	5.88e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK3—atherosclerosis	1.14e-05	5.85e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	1.14e-05	5.84e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	1.14e-05	5.83e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	1.14e-05	5.82e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	1.12e-05	5.76e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—atherosclerosis	1.11e-05	5.68e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	1.1e-05	5.63e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	1.09e-05	5.59e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.09e-05	5.57e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—atherosclerosis	1.08e-05	5.54e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	1.08e-05	5.53e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.08e-05	5.52e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARA—atherosclerosis	1.07e-05	5.46e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.05e-05	5.39e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.04e-05	5.34e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.04e-05	5.33e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AGT—atherosclerosis	1.03e-05	5.29e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	1.03e-05	5.28e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.03e-05	5.27e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—INS—atherosclerosis	1.02e-05	5.23e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.02e-05	5.22e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.02e-05	5.22e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOE—atherosclerosis	1.01e-05	5.18e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CAV1—atherosclerosis	1e-05	5.14e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1e-05	5.13e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	1e-05	5.13e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOA1—atherosclerosis	1e-05	5.12e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	9.99e-06	5.11e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	9.96e-06	5.1e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOB—atherosclerosis	9.76e-06	5e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	9.66e-06	4.95e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—atherosclerosis	9.5e-06	4.86e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—atherosclerosis	9.41e-06	4.82e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—atherosclerosis	9.36e-06	4.79e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—LPL—atherosclerosis	9.32e-06	4.77e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	9.24e-06	4.73e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—atherosclerosis	9.15e-06	4.69e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	9.14e-06	4.68e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GPX1—atherosclerosis	9.09e-06	4.66e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NOS3—atherosclerosis	8.95e-06	4.58e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CD36—atherosclerosis	8.86e-06	4.53e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—atherosclerosis	8.82e-06	4.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	8.75e-06	4.48e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—atherosclerosis	8.68e-06	4.44e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—INS—atherosclerosis	8.65e-06	4.43e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	8.49e-06	4.35e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—atherosclerosis	8.47e-06	4.34e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—atherosclerosis	8.39e-06	4.3e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—atherosclerosis	8.36e-06	4.28e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARA—atherosclerosis	8.23e-06	4.22e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—atherosclerosis	8.19e-06	4.19e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AGT—atherosclerosis	7.97e-06	4.08e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—atherosclerosis	7.93e-06	4.06e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—atherosclerosis	7.81e-06	4e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOE—atherosclerosis	7.81e-06	4e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CAV1—atherosclerosis	7.74e-06	3.96e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOA1—atherosclerosis	7.72e-06	3.95e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—atherosclerosis	7.71e-06	3.95e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NOS3—atherosclerosis	7.58e-06	3.88e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	7.54e-06	3.86e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—atherosclerosis	7.28e-06	3.73e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	7.05e-06	3.61e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	6.96e-06	3.56e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—atherosclerosis	6.94e-06	3.55e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—atherosclerosis	6.8e-06	3.48e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	6.72e-06	3.44e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—INS—atherosclerosis	6.67e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—atherosclerosis	6.39e-06	3.27e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—atherosclerosis	6.12e-06	3.13e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—atherosclerosis	5.9e-06	3.02e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NOS3—atherosclerosis	5.85e-06	3e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—atherosclerosis	5.35e-06	2.74e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—atherosclerosis	4.12e-06	2.11e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—atherosclerosis	3.49e-06	1.79e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—atherosclerosis	2.69e-06	1.38e-05	CbGpPWpGaD
